Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Liabilities and Shareholders Equity: 2022-2025

Historic Liabilities and Shareholders Equity for NewGenIvf (NIVF) over the last 4 years, with Sep 2025 value amounting to $35,558.4 billion.

  • NewGenIvf's Liabilities and Shareholders Equity was N/A to $35,558.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $35,558.4 billion, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 20.26% down from last year.
  • According to the latest figures from Q3 2025, NewGenIvf's Liabilities and Shareholders Equity is $35,558.4 billion, which was up 239,969,037.33% from $14.8 million recorded in Q2 2025.
  • NewGenIvf's Liabilities and Shareholders Equity's 5-year high stood at $35,558.4 billion during Q3 2025, with a 5-year trough of $2.9 million in Q4 2022.
  • Over the past 3 years, NewGenIvf's median Liabilities and Shareholders Equity value was $9.7 million (recorded in 2023), while the average stood at $8,889.6 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 54.46% in 2023, then decreased by 20.26% in 2024.
  • MRQ analysis of 4 years shows NewGenIvf's Liabilities and Shareholders Equity stood at $2.9 million in 2022, then surged by 54.46% to $4.5 million in 2023, then dropped by 20.26% to $3.6 million in 2024, then soared by 993,877,438.47% to $35,558.4 billion in 2025.
  • Its Liabilities and Shareholders Equity was $35,558.4 billion in Q3 2025, compared to $14.8 million in Q2 2025 and $3.6 million in Q4 2024.